TrialPanorama/TrialPanorama-database huggingface dataset:
Study 31326397 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 31326397 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 31328895 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31328895 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31328895 — Surrogate Endpoint (SUR): Blood pressure
Study 31328895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31328895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31328895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31329854 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 31331295 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 31331342 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31331370 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 31331393 — Predictive Biomarker (PRD): PSMB7 mRNA
Genes: PSMB7; Z
Study 31331393 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study 31331399 — Predictive Biomarker (PRD): DNMT3B mRNA
Genes: DNMT3B
Study 31331399 — Predictive Biomarker (PRD): CDKN2B mRNA
Genes: CDKN2B; MTS2
Study 31331399 — Predictive Biomarker (PRD): CDA mRNA
Genes: CDA; CDD
Study 31331399 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 31331399 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 31331701 — Predictive Biomarker (PRD): NR4A3 mRNA
Genes: NR4A3; CHN; CSMF; MINOR; NOR1; TEC
Study 31332068 — Predictive Biomarker (PRD): WWTR1 mRNA
Genes: WWTR1; TAZ
Study 31332649 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31333456 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31335321 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31336587 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 31336587 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 31340982 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 31341663 — Surrogate Endpoint (SUR): Blood pressure
Study 31342904 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 31343665 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 31344312 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 31345012 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31345012 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 31346927 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31346927 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 31346932 — Surrogate Endpoint (SUR): Blood pressure
Study 31349390 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 31350201 — Predictive Biomarker (PRD): SERPINB3 mRNA
Genes: SERPINB3; SCCA; SCCA1
Study 31350244 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 31350244 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 31350306 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 31351267 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 31351267 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 31351267 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31351267 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 31351452 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31351862 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 31352850 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 31353421 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31353854 — Safety Biomarker (SAF): miR-1
Study 31353854 — Safety Biomarker (SAF): miR-133a
Study 31353854 — Safety Biomarker (SAF): miR-206
Genes: MIR206
Study 31355009 — Surrogate Endpoint (SUR): Blood pressure
Study 31355926 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 31356140 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31357891 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 31357891 — Predictive Biomarker (PRD): FANCC
Genes: FAC; FA3
Study 31358485 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 31358485 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 31360988 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 31361205 — Predictive Biomarker (PRD): EMB mRNA
Genes: EMB
Study 31362654 — Predictive Biomarker (PRD): BCL11A mRNA
Genes: BCL11A; CTIP1; EVI9; KIAA1809; ZNF856
Study 31364010 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31364233 — Surrogate Endpoint (SUR): Blood pressure
Study 31364979 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31365116 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 31366074 — Predictive Biomarker (PRD): GAL3ST1 mRNA
Genes: GAL3ST1; CST
Study 31367468 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31367468 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study 31367691 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 31368034 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31368441 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 31368718 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31368837 — Predictive Biomarker (PRD): FURIN mRNA
Genes: FURIN; FUR; PACE; PCSK3
Study 31369089 — Surrogate Endpoint (SUR): Serum calcium
Study 31369089 — Surrogate Endpoint (SUR): Serum creatinine
Study 31369102 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study 31369562 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 31369720 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31370954 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 31371345 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 31371644 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31374571 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 31375469 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 31376874 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 31377265 — Predictive Biomarker (PRD): SLC16A2 mRNA
Genes: SLC16A2; MCT7; MCT8; XPCT
Study 31377694 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 31377694 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 31377849 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 31378695 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 31378695 — Predictive Biomarker (PRD): FCGR1A mRNA
Genes: FCGR1A; FCG1; FCGR1; IGFR1
Study 31378695 — Predictive Biomarker (PRD): GBP1 mRNA
Genes: GBP1
Study 31378695 — Predictive Biomarker (PRD): GBP4 mRNA
Genes: GBP4
Study 31378695 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study 31378695 — Predictive Biomarker (PRD): KLRC1 mRNA
Genes: KLRC1; NKG2A
Study 31378695 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 31381524 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 31381526 — Predictive Biomarker (PRD): DBNL mRNA
Genes: DBNL; CMAP; SH3P7; PP5423
Study 31383812 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31383812 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31383812 — Predictive Biomarker (PRD): Hormone receptor
Study 31384309 — Surrogate Endpoint (SUR): Blood pressure
Study 31384312 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31384312 — Predictive Biomarker (PRD): Hormone receptor
Study 31384956 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 31384956 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 31385389 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31385617 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 31389718 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31391177 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31391334 — Predictive Biomarker (PRD): MAPK1 mRNA
Genes: MAPK1; ERK2; PRKM1; PRKM2
Study 31391334 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31391334 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31391862 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31392200 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study 31392710 — Predictive Biomarker (PRD): SHC1 mRNA
Genes: SHC1; SHC; SHCA
Study 31394594 — Pharmacodynamic Biomarker (PDY): Auditory steady-state response
Study 31394596 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study 31395124 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 31395751 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 31395751 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 31395751 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 31395751 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 31395751 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31398081 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 31398081 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31398082 — Pharmacodynamic Biomarker (PDY): Cyclin-dependent kinase 1
Genes: CDK1; CDC2; CDC28A; CDKN1; P34CDC2
Study 31399043 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 31399043 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 31399936 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 31400325 — Pharmacodynamic Biomarker (PDY): Platelet-derived growth factor B
Genes: PDGFB; PDGF2; SIS
Study 31401102 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31401102 — Predictive Biomarker (PRD): FCGR2A mRNA
Genes: FCGR2A; CD32; FCG2; FCGR2A1; IGFR2
Study 31401102 — Predictive Biomarker (PRD): FCGR3A mRNA
Genes: FCGR3A; CD16A; FCG3; FCGR3; IGFR3
Study 31405822 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 31405822 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 31406569 — Surrogate Endpoint (SUR): Blood pressure
Study 31407130 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 31407130 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 31407236 — Predictive Biomarker (PRD): SERPINF1 mRNA
Genes: SERPINF1; PEDF; PIG35
Study 31407236 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31408438 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 31408438 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31408438 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31408438 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31409407 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31410779 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 31410787 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 31411386 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 31412732 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 31412874 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 31412874 — Surrogate Endpoint (SUR): Blood pressure
Study 31412935 — Predictive Biomarker (PRD): EPHA2 mRNA
Genes: EPHA2; ECK
Study 31412935 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 31413142 — Safety Biomarker (SAF): Interleukin 12
Study 31413177 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study 31413865 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31413923 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 31415245 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31415245 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study 31416921 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31421008 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 31421111 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31421324 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 31421324 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31421471 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31421641 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 31421641 — Surrogate Endpoint (SUR): Blood pressure
Study 31421657 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 31421657 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 31422126 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study 31423298 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 31427205 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31427205 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31428530 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 31428530 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 31428530 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31431673 — Predictive Biomarker (PRD): Epithelial cadherin
Genes: CDH1; CDHE; UVO
Study 31431673 — Predictive Biomarker (PRD): GFRA1 mRNA
Genes: GFRA1; GDNFRA; RETL1; TRNR1
Study 31431998 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31434508 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 31434793 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 31434793 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 31434940 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 31434940 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31438761 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31439037 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 31439037 — Predictive Biomarker (PRD): CD8A mRNA
Genes: CD8A; MAL
Study 31439037 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 31439037 — Predictive Biomarker (PRD): GZMK mRNA
Genes: GZMK; TRYP2
Study 31439537 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study 31439586 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 31439614 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 31439614 — Predictive Biomarker (PRD): Microsatellite instability
Study 31440945 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 31441881 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 31442103 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31442103 — Monitoring Biomarker (MOI): Cell-free DNA
Study 31442277 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31442817 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 31442817 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31443741 — Predictive Biomarker (PRD): CD200 mRNA
Genes: CD200; MOX1; MOX2; My033
Study 31443741 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31444250 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31446142 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 31446987 — Predictive Biomarker (PRD): DLL3 mRNA
Genes: DLL3
Study 31446987 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 31448496 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 31450823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31450823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31451409 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 31451445 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31451936 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 31455681 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study 31455681 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31455712 — Surrogate Endpoint (SUR): Blood pressure
Study 31456142 — Safety Biomarker (SAF): DRD2
Study 31456261 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 31462933 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 31462933 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 31462933 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31467127 — Predictive Biomarker (PRD): NOTCH1 mRNA
Genes: NOTCH1; TAN1
Study 31467583 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31467699 — Surrogate Endpoint (SUR): Blood pressure
Study 31470902 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 31471313 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 31471313 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 31471312 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study 31471324 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31471324 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31471433 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31472684 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 31472684 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 31472684 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study 31472684 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 31472684 — Predictive Biomarker (PRD): MRPL36 mRNA
Genes: MRPL36; BRIP1
Study 31472684 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 31472684 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 31472684 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study 31472684 — Predictive Biomarker (PRD): Epithelial cadherin
Genes: CDH1; CDHE; UVO
Study 31472684 — Predictive Biomarker (PRD): BARD1 mRNA
Genes: BARD1
Study 31473727 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31473943 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 31474600 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31475295 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 31476851 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 31476851 — Predictive Biomarker (PRD): IRF4 mRNA
Genes: IRF4; MUM1
Study 31477781 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 31477906 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31481121 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 31481511 — Predictive Biomarker (PRD): TGFBR1 mRNA
Genes: TGFBR1; ALK5; SKR4
Study 31481566 — Predictive Biomarker (PRD): SH3BP5 mRNA
Genes: SH3BP5; SAB
Study 31481633 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 31481800 — Predictive Biomarker (PRD): NRM mRNA
Genes: NRM; NRM29; UNQ555/PRO1112
Study 31481800 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31483485 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 31484498 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study 31484667 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study 31484667 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 31485435 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 31487564 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31488216 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 31488469 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 31489199 — Predictive Biomarker (PRD): MARS1 mRNA
Genes: MARS1; MARS
Study 31490308 — Safety Biomarker (SAF): Hyaluronic acid
Study 31491604 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 31491604 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31491604 — Predictive Biomarker (PRD): Hormone receptor